U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement

Aug.28.2025
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
The U.S. Bankruptcy Court in New York has approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., granting legal effect in the U.S. to its participation in a CA$32.5 billion (US$23.6 billion) tobacco litigation settlement. The case is considered one of the largest corporate restructurings in Canadian history and also involves Japan Tobacco International (JTI), Philip Morris International (PMI), and British American Tobacco (BAT).

Key Points

 

  • Court Ruling: U.S. Bankruptcy Court approved and recognized Imperial Tobacco Canada’s restructuring plan under Chapter 15 of the U.S. Bankruptcy Code.
  • Settlement Amount: The three tobacco companies will pay CA$32.5 billion (US$23.6 billion), including CA$12.5 billion (US$9.1 billion) in upfront cash, with the remainder from net after-tax income over the next 20 years.
  • Background: In 2019, Imperial Tobacco Canada, JTI-Macdonald, and Rothman Benson & Hedges faced claims totaling CA$1 trillion and entered insolvency proceedings.
  • International Dimension: While Imperial Tobacco Canada does not sell products overseas, its supply chain and inventory involve the U.S., along with legacy pension liabilities.

 


 

2Firsts, August 28, 2025 —— According to Law360 on August 26, U.S. Bankruptcy Judge John P. Mastando III of the Southern District of New York formally approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., thereby confirming the legal effect in the U.S. of its participation in the CA$32.5 billion (US$23.6 billion) tobacco litigation settlement.

 

The agreement is regarded as one of the largest restructurings in Canadian history. Imperial Tobacco Canada’s U.S. counsel, Jennifer Feldsher, stated in court: “This is one of the largest, if not the largest, restructurings in Canadian history.”

 

Imperial Tobacco Canada is one of the three largest tobacco distributors in Canada and a subsidiary of British American Tobacco (BAT). In 2019, the company, along with JTI-Macdonald Corp. and Rothman, Benson & Hedges Inc., entered Canadian insolvency proceedings in response to CA$1 trillion (US$725.6 billion) in health-related tobacco claims.

 

  • JTI-Macdonald Corp. is the Canadian subsidiary of Japan Tobacco International (JTI).
  • Rothmans, Benson & Hedges Inc. is the Canadian arm of Philip Morris International (PMI).
  • Imperial Tobacco Canada Ltd. is the Canadian subsidiary of British American Tobacco (BAT).

 

After years of mediation—delayed significantly by the COVID-19 pandemic—the parties reached a settlement in 2024. Under the terms, the three companies will pay into a CA$32.5 billion (US$23.6 billion) fund to compensate class action claimants and reimburse Canadian provincial governments for healthcare costs related to tobacco use.

 

The agreement stipulates that nearly CA$12.5 billion (US$9.1 billion) will be paid upfront in cash, while the remainder will be drawn from the majority of the companies’ net after-tax income over the next 20 years.

 

Feldsher noted that this settlement is the largest of its kind since the 1998 Master Settlement Agreement in the U.S., when American tobacco companies agreed to pay more than US$200 billion.

 

Imperial Tobacco Canada filed its restructuring plan in October 2024, which was approved by a Canadian court in March 2025. Although Imperial Tobacco Canada does not sell tobacco outside of Canada, its supply chain passes through the U.S., where it also stores inventory. The company also resolved legacy pension liabilities stemming from acquisitions of U.S. companies.

 

Subsequently, Imperial Tobacco Canada sought U.S. recognition of the plan. Judge Mastando granted the request, recognized the Canadian court-appointed plan administrator, and issued an order barring unauthorized solicitation of claims in the case.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
According to recent LinkedIn posts from people at VAPORESSO, SMOORE and a German distribution partner, vape brand DOJO will begin rolling out a new global brand identity on September 1, 2026, led by a redesigned handwritten logo. The new visual system will be gradually applied across product packaging, marketing materials and digital assets over the following months. Fabio Corsaro, Head of Marketing and Purchasing at MG Wesel GmbH, said the rebrand was related to trademark issues, but that explanation has not been publicly confirmed by DOJO, VAPORESSO or SMOORE. DOJO is currently promoting its Blast X product in Germany.
Aug.31
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
U.S. President Donald Trump has named Pastor Darrell Scott to serve as an adviser on tobacco health issues on the Centers for Disease Control and Prevention’s Advisory Committee to the Director. Trump said Scott would focus on the burden of tobacco-related disease and help examine ways to protect Americans from dangerous tobacco products while supporting solutions that reduce harm. Scott’s public career has largely centered on faith leadership, community advocacy and politics.
Sep.02
BAT Calls for Retailer Input in Future Nicotine Regulations
BAT Calls for Retailer Input in Future Nicotine Regulations
British American Tobacco (BAT) has called for stronger retailer involvement in shaping future nicotine product regulations in the UK, arguing that frontline market feedback should be considered during policy development. BAT said retailers provide direct insight into consumer behavior, market changes and regulatory implementation challenges. The comments come as the UK nicotine market undergoes regulatory changes, including the disposable vape ban, Vaping Products Duty and efforts to address illicit vape sales.
Jul.29
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08
CCPIT Says Trade Friction Index for China-Related Electronics Sector Remains High, With Vape Products Among Areas of Focus
CCPIT Says Trade Friction Index for China-Related Electronics Sector Remains High, With Vape Products Among Areas of Focus
China Council for the Promotion of International Trade (CCPIT) held its July regular press conference on July 31, 2026, releasing the May 2026 Global Economic and Trade Friction Index. CCPIT spokesperson Yang Fan said the global trade friction index stood at 95 in May, remaining at a medium-to-high level. By industry, the electronics sector recorded the highest trade friction index among 13 monitored industries. In China-related trade frictions, the index stood at 93, with electronics products including drones, chips and vape products among areas where friction remained elevated.
Aug.03
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19